Tag: Vaccines
COVID-19 Vaccination Safe During Pregnancy
No differences seen in neonatal and early infant outcomes for offspring exposed, not exposed to vaccine in utero
Humoral Response in Hemodialysis Patients Stronger With mRNA-1273
Antibody responses at six to seven and 12 weeks after the second dose stronger with mRNA-1273 versus BNT162b2
Vaccination in Pregnancy Prevents COVID-19 Hospitalization in Infants
Maternal completion of two-dose primary mRNA COVID-19 vaccination series 61 percent effective for preventing COVID-19 hospitalization
Antibodies Persist for Infants Born to COVID-19-Vaccinated Moms
Anti-spike antibody levels lower in infants born to mothers who were infected with SARS-CoV-2 at 20 to 32 weeks of gestation
Vaccine Effectiveness Up After Three COVID-19 Vaccine Doses
VE lower during omicron- versus delta-predominant period at all time points; waned with increasing time since vaccination
Physician’s Briefing Weekly Coronavirus Roundup
FDA Postpones Decision on Pfizer COVID-19 Vaccine for Under 5s
Step was taken after Pfizer notified the agency it would like to wait until data are available on a three-dose regimen
Adverse Events After BNT162b2 Do Not Differ for Cancer Patients
Among patients with cancer, pain at the injection site was less likely after dose 1 for those receiving active treatment
Homologous, Heterologous COVID-19 Boosters Are Immunogenic
Antibody neutralizing titers against SARS-CoV-2 D614G pseudovirus increased by factor of 4 to 73 for all combinations
CDC Backs Full Approval of Moderna COVID-19 Vaccine
Moderna vaccine is the second COVID-19 vaccine to receive full approval from both the FDA and CDC
